Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Kaat Beunen"'
Autor:
Kaat Beunen, Nancy Van Wilder, Dominique Ballaux, Gerd Vanhaverbeke, Youri Taes, Xavier-Philippe Aers, Frank Nobels, Joke Marlier, Dahae Lee, Joke Cuypers, Vanessa Preumont, Sarah E. Siegelaar, Rebecca C. Painter, Annouschka Laenen, Pieter Gillard, Chantal Mathieu, Katrien Benhalima
Publikováno v:
BMC Pregnancy and Childbirth, Vol 23, Iss 1, Pp 1-11 (2023)
Abstract Background Despite increasing use of continuous glucose monitoring (CGM) and continuous subcutaneous insulin infusion (CSII, insulin pumps) in type 1 diabetes (T1D) in pregnancy, achieving recommended pregnancy glycaemic targets (3.5–7.8 m
Externí odkaz:
https://doaj.org/article/c24146084b6c4636aa5284b05e5710df
Autor:
Kaat Beunen, Lies Vercauter, Paul Van Crombrugge, Carolien Moyson, Johan Verhaeghe, Sofie Vandeginste, Hilde Verlaenen, Chris Vercammen, Toon Maes, Els Dufraimont, Nele Roggen, Christophe De Block, Yves Jacquemyn, Farah Mekahli, Katrien De Clippel, Annick Van Den Bruel, Anne Loccufier, Annouschka Laenen, Roland Devlieger, Chantal Mathieu, Katrien Benhalima
Publikováno v:
Frontiers in Endocrinology, Vol 13 (2022)
AimsTo characterize women with gestational diabetes mellitus (GDM) positive for type 1 diabetes-related autoimmune antibodies (T1D-related autoantibodies) in pregnancy and to evaluate their risk for long-term glucose intolerance.MethodsIn a multi-cen
Externí odkaz:
https://doaj.org/article/682a21f0f63f4fdcaa3ad584d86d0ebc
Autor:
Kaat Beunen, Katrien Benhalima
Publikováno v:
Acta Diabetologica. 60:859-860
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::08a8ee42960bbfdd3216a7d23c8cccec
https://doi.org/10.1007/s00592-023-02089-w
https://doi.org/10.1007/s00592-023-02089-w
Autor:
Yves Jacquemyn, Farah Mekahli, Katrien Benhalima, Kaat Beunen, Johan Verhaeghe, Sofie Vandeginste, Annouschka Laenen, Anne Loccufier, Chris Vercammen, Astrid Neys, Chantal Mathieu, Nele Roggen, Christophe De Block, Annick Van den Bruel, Els Dufraimont, Toon Maes, Katrien De Clippel, Carolien Moyson, Hilde Verlaenen, Roland Devlieger, Paul Van Crombrugge
Publikováno v:
Acta diabetologica
AIMS: To determine the fasting plasma glucose (FPG) level at which an oral glucose tolerance test (OGTT) could be avoided to screen for gestational diabetes (GDM) and to evaluate the characteristics of women across this FPG threshold. METHODS: A mult
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c28179b59d1d601681e47c986df1dc0a
https://lirias.kuleuven.be/handle/123456789/683489
https://lirias.kuleuven.be/handle/123456789/683489
Publikováno v:
Journal of Clinical Medicine
Journal of Clinical Medicine, Vol 10, Iss 1257, p 1257 (2021)
Journal of Clinical Medicine, Vol 10, Iss 1257, p 1257 (2021)
The incidence of gestational diabetes mellitus (GDM) is increasing worldwide. This has a significant effect on the health of the mother and offspring. There is no doubt that screening for GDM between 24 and 28 weeks is important to reduce the risk of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e01f603e8ba92b2b354414ee5ef22ae
https://pubmed.ncbi.nlm.nih.gov/33803650
https://pubmed.ncbi.nlm.nih.gov/33803650
Publikováno v:
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Gestational diabetes mellitus (GDM) is a frequent medical complication during pregnancy. Screening and diagnostic practices for GDM are inconsistent across the world. This narrative review includes data from 87 observational studies and randomized co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5928d9416cbf9aff9a4b5f20f6b6c2c
https://lirias.kuleuven.be/handle/123456789/678158
https://lirias.kuleuven.be/handle/123456789/678158